ICAD（頭蓋内アテローム性動脈硬化症）病理の世界市場 2020年

• 英文タイトル：Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201115634 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、ICAD（頭蓋内アテローム性動脈硬化症）病理の世界市場を調査対象にし、ICAD（頭蓋内アテローム性動脈硬化症）病理の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（第1分割、ステント、PTAバルーンに分割）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Stryker、MicroPort、Balt、TERUMO、Acandis ・企業別売上、市場シェア ・ICAD（頭蓋内アテローム性動脈硬化症）病理の地域別市場分析 ・ICAD（頭蓋内アテローム性動脈硬化症）病理の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ICAD（頭蓋内アテローム性動脈硬化症）病理のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ICAD（頭蓋内アテローム性動脈硬化症）病理のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ICAD（頭蓋内アテローム性動脈硬化症）病理の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ICAD（頭蓋内アテローム性動脈硬化症）病理の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ICAD（頭蓋内アテローム性動脈硬化症）病理の種類別市場規模2015-2020：第1分割、ステント、PTAバルーンに分割 ・ICAD（頭蓋内アテローム性動脈硬化症）病理の用途別市場規模2015-2020：病院、クリニック、その他 ・ICAD（頭蓋内アテローム性動脈硬化症）病理の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The ICAD (Intracranial Atherosclerotic Disease) Pathology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global ICAD (Intracranial Atherosclerotic Disease) Pathology market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.4%% in the forecast period of 2020 to 2025 and will expected to reach USD 227.4 million by 2025, from USD 164.6 million in 2019.

Market segmentation
ICAD (Intracranial Atherosclerotic Disease) Pathology market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, ICAD (Intracranial Atherosclerotic Disease) Pathology market has been segmented into:
primarily split into
Stent
PTA Balloon

By Application, ICAD (Intracranial Atherosclerotic Disease) Pathology has been segmented into:
Hospital
Clinic
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global ICAD (Intracranial Atherosclerotic Disease) Pathology market presented in the report. This section sheds light on the sales growth of different regional and country-level ICAD (Intracranial Atherosclerotic Disease) Pathology markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global ICAD (Intracranial Atherosclerotic Disease) Pathology market.

The report offers in-depth assessment of the growth and other aspects of the ICAD (Intracranial Atherosclerotic Disease) Pathology market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share Analysis
ICAD (Intracranial Atherosclerotic Disease) Pathology competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, ICAD (Intracranial Atherosclerotic Disease) Pathology sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the ICAD (Intracranial Atherosclerotic Disease) Pathology sales, revenue and market share for each player covered in this report.

The major players covered in ICAD (Intracranial Atherosclerotic Disease) Pathology are:
Stryker
MicroPort
Balt
TERUMO
Acandis
Among other players domestic and global, ICAD (Intracranial Atherosclerotic Disease) Pathology market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

---

1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Overview
1.1 Product Overview and Scope of ICAD (Intracranial Atherosclerotic Disease) Pathology
1.2 Classification of ICAD (Intracranial Atherosclerotic Disease) Pathology by Type
1.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type in 2019
1.2.3 primarily split into
1.2.4 Stent
1.2.5 PTA Balloon
1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Application
1.3.1 Overview: Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Regions
1.4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of ICAD (Intracranial Atherosclerotic Disease) Pathology (2015-2025)
1.4.3 North America (USA, Canada and Mexico) ICAD (Intracranial Atherosclerotic Disease) Pathology Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) ICAD (Intracranial Atherosclerotic Disease) Pathology Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) ICAD (Intracranial Atherosclerotic Disease) Pathology Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) ICAD (Intracranial Atherosclerotic Disease) Pathology Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) ICAD (Intracranial Atherosclerotic Disease) Pathology Status and Prospect (2015-2025)
2 Company Profiles
2.1 Stryker
2.1.1 Stryker Details
2.1.2 Stryker Major Business
2.1.3 Stryker SWOT Analysis
2.1.4 Stryker Product and Services
2.1.5 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, Gross Margin and Market Share (2018-2019)
2.2 MicroPort
2.2.1 MicroPort Details
2.2.2 MicroPort Major Business
2.2.3 MicroPort SWOT Analysis
2.2.4 MicroPort Product and Services
2.2.5 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, Gross Margin and Market Share (2018-2019)
2.3 Balt
2.3.1 Balt Details
2.3.2 Balt Major Business
2.3.3 Balt SWOT Analysis
2.3.4 Balt Product and Services
2.3.5 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, Gross Margin and Market Share (2018-2019)
2.4 TERUMO
2.4.1 TERUMO Details
2.4.2 TERUMO Major Business
2.4.3 TERUMO SWOT Analysis
2.4.4 TERUMO Product and Services
2.4.5 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, Gross Margin and Market Share (2018-2019)
2.5 Acandis
2.5.1 Acandis Details
2.5.2 Acandis Major Business
2.5.3 Acandis SWOT Analysis
2.5.4 Acandis Product and Services
2.5.5 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 ICAD (Intracranial Atherosclerotic Disease) Pathology Players Market Share
3.2.2 Top 10 ICAD (Intracranial Atherosclerotic Disease) Pathology Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Market Share by Regions
4.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
4.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
4.5 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
5 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries
5.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries (2015-2020)
5.2 USA ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
5.3 Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
5.4 Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
6 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries
6.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries (2015-2020)
6.2 Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
6.3 UK ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
6.4 France ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
6.5 Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
6.6 Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
7 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries
7.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries (2015-2020)
7.2 China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
7.3 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
7.4 Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
7.5 India ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
8 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries
8.1 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries (2015-2020)
8.2 Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
8.3 Argentina ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries
9.1 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries (2015-2020)
9.2 Saudi Arabia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
9.3 UAE ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
9.4 Egypt ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
9.5 South Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Market Share by Type (2015-2020)
10.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast by Type (2019-2024)
10.3 primarily split into Revenue Growth Rate (2015-2025)
10.4 Stent Revenue Growth Rate (2015-2025)
10.5 PTA Balloon Revenue Growth Rate (2015-2025)
11 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Segment by Application
11.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (2015-2020)
11.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast (2021-2025)
12.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast (2021-2025)
12.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast by Regions (2021-2025)
12.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Forecast (2021-2025)
12.4 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Forecast (2021-2025)
12.6 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of ICAD (Intracranial Atherosclerotic Disease) Pathology by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Stryker Corporate Information, Location and Competitors
Table 7. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Major Business
Table 8. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Total Revenue (USD Million) (2017-2018)
Table 9. Stryker SWOT Analysis
Table 10. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product and Solutions
Table 11. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. MicroPort Corporate Information, Location and Competitors
Table 13. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Major Business
Table 14. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Total Revenue (USD Million) (2018-2019)
Table 15. MicroPort SWOT Analysis
Table 16. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product and Solutions
Table 17. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Balt Corporate Information, Location and Competitors
Table 19. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Major Business
Table 20. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Total Revenue (USD Million) (2017-2018)
Table 21. Balt SWOT Analysis
Table 22. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product and Solutions
Table 23. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. TERUMO Corporate Information, Location and Competitors
Table 25. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Major Business
Table 26. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Total Revenue (USD Million) (2017-2018)
Table 27. TERUMO SWOT Analysis
Table 28. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product and Solutions
Table 29. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Acandis Corporate Information, Location and Competitors
Table 31. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Major Business
Table 32. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Total Revenue (USD Million) (2017-2018)
Table 33. Acandis SWOT Analysis
Table 34. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product and Solutions
Table 35. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) by Players (2015-2020)
Table 37. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Players (2015-2020)
Table 38. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) by Regions (2015-2020)
Table 39. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Regions (2015-2020)
Table 40. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries (2015-2020)
Table 41. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries (2015-2020)
Table 42. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) by Countries (2015-2020)
Table 43. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) by Countries (2015-2020)
Table 44. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries (2015-2020)
Table 45. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries (2015-2020)
Table 46. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) by Countries (2015-2020)
Table 47. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries (2015-2020)
Table 48. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) by Type (2015-2020)
Table 49. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Type (2015-2020)
Table 50. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Type (2021-2025)
Table 51. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2015-2020)
Table 52. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Application (2015-2020)
Table 53. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Application (2021-2025)
Table 54. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Picture
Figure 2. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type in 2019
Figure 3. primarily split into Picture
Figure 4. Stent Picture
Figure 5. PTA Balloon Picture
Figure 6. ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application in 2019
Figure 7. Hospital Picture
Figure 8. Clinic Picture
Figure 9. Other Picture
Figure 10. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Players in 2019
Figure 18. Global Top 5 Players ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share in 2019
Figure 19. Global Top 10 Players ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Regions (2015-2020)
Figure 23. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Regions in 2018
Figure 24. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
Figure 25. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
Figure 27. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
Figure 29. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries (2015-2020)
Figure 30. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries in 2019
Figure 31. USA ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
Figure 32. Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
Figure 33. Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
Figure 34. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries (2015-2020)
Figure 35. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries in 2019
Figure 36. Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
Figure 37. UK ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
Figure 38. France ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
Figure 39. Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
Figure 40. Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries in 2019
Figure 43. China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
Figure 44. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
Figure 45. Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
Figure 46. India ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
Figure 48. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries (2015-2020)
Figure 49. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries in 2019
Figure 50. Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
Figure 51. Argentina ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
Figure 55. UAE ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
Figure 56. Egypt ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
Figure 57. South Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2015-2020)
Figure 58. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Type (2015-2020)
Figure 59. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Type in 2019
Figure 60. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share Forecast by Type (2021-2025)
Figure 61. Global primarily split into Revenue Growth Rate (2015-2020)
Figure 62. Global Stent Revenue Growth Rate (2015-2020)
Figure 63. Global PTA Balloon Revenue Growth Rate (2015-2020)
Figure 64. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Application (2015-2020)
Figure 65. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Application in 2019
Figure 66. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospital Revenue Growth Rate (2015-2020)
Figure 68. Global Clinic Revenue Growth Rate (2015-2020)
Figure 69. Global Other Revenue Growth Rate (2015-2020)
Figure 70. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Forecast (2021-2025)
Figure 74. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Forecast (2021-2025)
Figure 76. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel

---